Health · 1 views
Blood protein analysis suggests a lung disease drug could be fighting aging at the same time
In 2025, Insilico Medicine developed an experimental drug called rentosertib as a treatment for idiopathic pulmonary fibrosis, a severe age-related lung disease.
Summary
In 2025, Insilico Medicine developed an experimental drug called rentosertib as a treatment for idiopathic pulmonary fibrosis, a severe age-related lung disease. The drug works by inhibiting the protein TNIK, which is involved in both scar tissue formation in the lungs and fundamental hallmarks of biological aging.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Blocking a protein may reduce buildup of harmful aging cellsContinue reading
- My plea to MPs: this is the final chance to save the assisted dying bill. Make your mark on history | Polly ToynbeeContinue reading
- Beyond B cells: Rituximab response may reveal which kidney disease patients can stop steroidsContinue reading
- New survey highlights persistent cancer medication shortages across United StatesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow